Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231345189> ?p ?o ?g. }
- W4231345189 endingPage "699" @default.
- W4231345189 startingPage "692" @default.
- W4231345189 abstract "OBJECTIVE To report the results of treating patients with orbital pseudolymphomas with the anti-CD20 monoclonal antibody rituximab. PATIENTS AND METHODS Patients were included in the study if they had an orbital mass and biopsy-proven orbital pseudolymphomas between January 1, 1998, and December 31, 2005. The study focused on patients treated with rituximab. RESULTS Ninety-eight patients were evaluated, and the biopsy results revealed malignant non-Hodgkin lymphoma in 72 (73%); the other 26 (27%) had a pseudolymphoma. Eleven (42%) of the 26 patients with a pseudolymphoma were treated with rituximab, 375 mg/m2, intravenously each week for 4 doses, and 10 (91%) of the 11 responded. Seven patients were either treated with maintenance rituximab or successfully retreated with rituximab after relapse. None of the 10 responders has become refractory to rituximab. CONCLUSION Benign lymphoproliferative tumors are responsive to monoclonal antibody therapy targeted to B lymphocytes. Rituximab should be considered a treatment option for orbital pseudolymphomas. To report the results of treating patients with orbital pseudolymphomas with the anti-CD20 monoclonal antibody rituximab. Patients were included in the study if they had an orbital mass and biopsy-proven orbital pseudolymphomas between January 1, 1998, and December 31, 2005. The study focused on patients treated with rituximab. Ninety-eight patients were evaluated, and the biopsy results revealed malignant non-Hodgkin lymphoma in 72 (73%); the other 26 (27%) had a pseudolymphoma. Eleven (42%) of the 26 patients with a pseudolymphoma were treated with rituximab, 375 mg/m2, intravenously each week for 4 doses, and 10 (91%) of the 11 responded. Seven patients were either treated with maintenance rituximab or successfully retreated with rituximab after relapse. None of the 10 responders has become refractory to rituximab. Benign lymphoproliferative tumors are responsive to monoclonal antibody therapy targeted to B lymphocytes. Rituximab should be considered a treatment option for orbital pseudolymphomas." @default.
- W4231345189 created "2022-05-12" @default.
- W4231345189 creator A5004152557 @default.
- W4231345189 creator A5024505450 @default.
- W4231345189 creator A5025688165 @default.
- W4231345189 creator A5030603735 @default.
- W4231345189 creator A5032141490 @default.
- W4231345189 creator A5047113696 @default.
- W4231345189 creator A5071201232 @default.
- W4231345189 creator A5074099210 @default.
- W4231345189 creator A5084861549 @default.
- W4231345189 date "2007-06-01" @default.
- W4231345189 modified "2023-09-27" @default.
- W4231345189 title "Treatment of Benign Orbital Pseudolymphomas With the Monoclonal Anti-CD20 Antibody Rituximab" @default.
- W4231345189 cites W137167786 @default.
- W4231345189 cites W1485349309 @default.
- W4231345189 cites W1915689252 @default.
- W4231345189 cites W1967097575 @default.
- W4231345189 cites W1969100325 @default.
- W4231345189 cites W1969708825 @default.
- W4231345189 cites W1971043049 @default.
- W4231345189 cites W1971648508 @default.
- W4231345189 cites W1973722754 @default.
- W4231345189 cites W1975338840 @default.
- W4231345189 cites W1977466104 @default.
- W4231345189 cites W1979690593 @default.
- W4231345189 cites W1982135947 @default.
- W4231345189 cites W1984701801 @default.
- W4231345189 cites W1988622991 @default.
- W4231345189 cites W1988935270 @default.
- W4231345189 cites W1990191176 @default.
- W4231345189 cites W1994978650 @default.
- W4231345189 cites W1995293214 @default.
- W4231345189 cites W1998995111 @default.
- W4231345189 cites W2002666682 @default.
- W4231345189 cites W2013576526 @default.
- W4231345189 cites W2015680673 @default.
- W4231345189 cites W2016795467 @default.
- W4231345189 cites W2024378752 @default.
- W4231345189 cites W2029335580 @default.
- W4231345189 cites W2032026644 @default.
- W4231345189 cites W2034883079 @default.
- W4231345189 cites W2038675773 @default.
- W4231345189 cites W2041967452 @default.
- W4231345189 cites W2043495652 @default.
- W4231345189 cites W2043983872 @default.
- W4231345189 cites W2049063161 @default.
- W4231345189 cites W2050054887 @default.
- W4231345189 cites W2050707028 @default.
- W4231345189 cites W2058015212 @default.
- W4231345189 cites W2066388140 @default.
- W4231345189 cites W206701898 @default.
- W4231345189 cites W2068440335 @default.
- W4231345189 cites W2070719170 @default.
- W4231345189 cites W2070767321 @default.
- W4231345189 cites W2077912257 @default.
- W4231345189 cites W2081309258 @default.
- W4231345189 cites W2081525886 @default.
- W4231345189 cites W2085257327 @default.
- W4231345189 cites W2087252266 @default.
- W4231345189 cites W2089547461 @default.
- W4231345189 cites W2089909411 @default.
- W4231345189 cites W2090577658 @default.
- W4231345189 cites W2095044614 @default.
- W4231345189 cites W2099491948 @default.
- W4231345189 cites W2106542190 @default.
- W4231345189 cites W2108794832 @default.
- W4231345189 cites W2119423613 @default.
- W4231345189 cites W2124308070 @default.
- W4231345189 cites W2153665789 @default.
- W4231345189 cites W2162349919 @default.
- W4231345189 cites W2167635913 @default.
- W4231345189 cites W2168759512 @default.
- W4231345189 cites W2168926834 @default.
- W4231345189 cites W2169383281 @default.
- W4231345189 cites W2169578616 @default.
- W4231345189 cites W2207296174 @default.
- W4231345189 cites W2324304795 @default.
- W4231345189 cites W4239052964 @default.
- W4231345189 cites W4247231580 @default.
- W4231345189 cites W8022028 @default.
- W4231345189 cites W2086019281 @default.
- W4231345189 doi "https://doi.org/10.1016/s0025-6196(11)61189-0" @default.
- W4231345189 hasPublicationYear "2007" @default.
- W4231345189 type Work @default.
- W4231345189 citedByCount "25" @default.
- W4231345189 countsByYear W42313451892012 @default.
- W4231345189 countsByYear W42313451892013 @default.
- W4231345189 countsByYear W42313451892014 @default.
- W4231345189 countsByYear W42313451892015 @default.
- W4231345189 countsByYear W42313451892016 @default.
- W4231345189 countsByYear W42313451892017 @default.
- W4231345189 countsByYear W42313451892018 @default.
- W4231345189 countsByYear W42313451892019 @default.
- W4231345189 countsByYear W42313451892023 @default.
- W4231345189 crossrefType "journal-article" @default.
- W4231345189 hasAuthorship W4231345189A5004152557 @default.
- W4231345189 hasAuthorship W4231345189A5024505450 @default.